This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Zydus Cadila

Drug Names(s): ZYT1

Description: ZYT1 is a New Molecular Entity (NME) anti-dyslipidemic agent that acts as a thyroid homone receptor beta (TR-beta) agonist and mayprovide an alternative to statins or be an add-on to statin therapy.

ZYT1 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug